AddressPI Office 6
6th floor, Wing B, Maple House
149 Tottenham Court Road
Marie Curie Chair in Palliative and End of Life Care
Division of Psychiatry
Faculty of Brain Sciences
Since 2000 he has obtained over £6 million in peer-reviewed research income. He has successfully completed one of the largest prospective (n=1018) multi-centre palliative care studies (involving 18 sites across England) and published in the BMJ. He is the Chief Investigator on two large NIHR HTA funded grants: The PiPS2 study on prognostic indicators in palliative care (£832k); and MePFAC, a double blind randomised placebo controlled study of methylphenidate for cancer related fatigue (£1.4M). His total number of peer-reviewed publications is >100. His H-index is 37 (Google scholar). He has supervised five full-time PhD students to completion in regulation time and is currently supervising five further full time students.
Paddy Stone has been involved in the development of palliative medicine as an academic discipline. He was Chair of the Science Committee of the Association of Palliative Medicine (APM). He was a member of the NCRI Palliative Care Studies Group. He was Chair of the prognosis working group and a member of the cachexia and dyspnoea sub-groups. He was secretary of the Palliative Care Research Society for five years. He has formed research collaborations both nationally and internationally and his role as a research leader has been recognized by invitations to speak at international meetings and to serve on committees of learned and professional societies.
Paddy Stone is professor of palliative and end of life care at UCL. He
was educated at Wimbledon College, Gonville and Caius College, Cambridge
and St Batholomew's hospital, London. He qualified in 1990, obtained
the MRCP in 1993 and his MD in cancer related fatigue in 1999. He was
appointed as Senior Lecturer in Palliative Medicine at St George's
University of London (SGUL) in 2001 and was appointed head of the Marie
Curie Palliative Care Research Unit at UCL in 2014.
He has been a member of the APM since 1993. He was the chair of the APM Science committee (2012-2014). He was a member of the National Cancer Research Institute (NCRI) Palliative Care clinical studies group 2003-2010. He was the secretary of the Palliative Care Research Society (UK) 1999-2004.
research interests include the mechanisms and management of cancer
related fatigue, prognostication in advanced cancer and quality of life
and symptom assessment. He is the Chief Investigator on two large NIHR HTA funded grants: The PiPS2 study on prognostic indicators in palliative care (£832k); and MePFAC, a double blind randomised placebo controlled study of methylphenidate for cancer related fatigue (£1.4M).